Rasagiline Tablet
Product Images NDC 51407-008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 51407-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mock (51407-008-30TBD- Rasaglinie Tablets 0.5 mg)

Mock (51407-008-30TBD- Rasaglinie Tablets 0.5 mg)
Label for Rasagiline Tablets 0.5 mg by Golden State Medical Supply, Inc. The label includes NDC 51407-008-30 and indicates a package of 30 tablets for prescription use. It provides storage instructions, child safety warnings, and dosage information, noting each tablet contains 0.5 mg rasagiline (0.78 mg rasagiline mesylate).*
FDA Label Image

Mock (51407-009-30TBD- Rasaglinie Tablets 1 mg)

Mock (51407-009-30TBD- Rasaglinie Tablets 1 mg)
Rasagiline 1 mg tablets label from Golden State Medical Supply, Inc. The label shows NDC 51407-009-30 with a 30-tablet count. It includes dosage details, child-resistant packaging information, storage instructions, and directs pharmacists to dispense a medication guide with each prescription.*
FDA Label Image

Chemical Structure (Structure01)

Chemical Structure (Structure01)
Chemical structure of rasagiline mesylate, showing a bicyclic amine attached to a methanesulfonic acid (mesylate) group and an alkyne side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.